K&F’s first post-pandemic jury trial resulted in a $10.6 million verdict for the widow of a mesothelioma victim.

Suit alleges pharmaceutical companies liable for drug injuries

In Ohio and across the nation, patients have the right to be fully informed about any medications they are prescribed so that they can make sound decisions about their own health. In another state, a man has recently filed a pharmaceutical litigation lawsuit in federal court regarding the drug injuries he suffered. The patient names a number of pharmaceutical companies as defendants, alleging product liability and negligence.

The complaint, recently filed in U.S. District Court, names as defendants Takeda Pharmaceuticals America, Takeda Pharmaceuticals USA, Takeda Pharmaceuticals International and Takeda Global Research & Development Center. The plaintiff alleges that the defendants manufactured and sold to consumers a diabetes medication that was defective and harmful. The man claims that, due to the side effects of the drug he was taking for his diabetes, Actos, he suffered physical injuries.

The plaintiff seeks to hold the defendants responsible for his bladder cancer, as the side effects of Actos contributed to the development of this cancer. Furthermore, all of the defendants failed to warn patients of any of the potentially harmful effects of the drug. For these multiple failures and negligence on the part of the defendants, a trial by jury has been requested.

The man is seeking compensatory, punitive and exemplary damages and interest, as well as all court costs and any further relief as granted by the court. If any residents of Ohio have similarly suffered drug injuries, an attorney with experience in pharmaceutical litigation will be able to help the injured individuals understand their rights. The skill and knowledge of such a lawyer could prove invaluable in a legal fight for justice and compensation.

Source: pennrecord.com, “Takeda accused of negligence for negative side effects of Actos diabetes drug“, Louie Torres, June 12, 2017

Archives

$120 Million Settlement

To 15,000 Asbestos Victims

$20 Million Verdict

Mesothelioma

$17 Million Verdict

Mesothelioma

$8.2 Million Verdict

Mesothelioma

White Paper Read Now2
White Paper Read Now